Europäische Marktprognose für Transfektionsreagenzien und -geräte bis 2030 – Regionale Analyse – nach Produkt (Reagenzien und Instrumente), Methode (virale Methoden, nicht-virale Methoden und Hybridmethoden), Anwendung (biomedizinische Forschung, Proteinproduktion und Therapeutikaverabreichung) und Endnutzer (Akademien und Forschungsinstitute sowie Pharma- und Biotechnologieunternehmen)
Strategische Initiativen von Unternehmen treiben den europäischen Markt für Transfektionsreagenzien und -geräte an
Die Transfektion ist der komplexe Schritt im Gesamtprozess der Entwicklung eines viralen Vektors, der Adenovirus, Adeno-assoziiertes Virus und Lentivirus umfasst. Mit der Skalierung der Herstellungsprozesse muss auch die transiente Transfektion gesteigert werden. Anbieter von Prozessgeräten, Arzneimittelentwickler und Rohstofflieferanten konzentrieren sich auf Kooperationen, um kostengünstige, praktische und plattformfähige Lösungen für die schnelle Entwicklung und Skalierung von Herstellungsprozessen für virale Vektoren zu entwickeln. In kleinem Maßstab, mit geplanten Materialmengen und Transfer- und Mischzeiten, wird die Transfektion von Zellen mit mehreren Plasmiden möglich. Für die Skalierung ist Erfahrung in der Industrialisierung des Transfektionsschritts erforderlich, da die meisten Unternehmen nur über Transfektionserfahrung auf Laborebene verfügen. Das Volumen an Zellkulturmedien und Transfektionsreagenzien, das für die Skalierung des Prozesses auf ein höheres Niveau erforderlich ist, kann jedoch unpraktisch sein, was den Optimierungsbedarf unterstreicht. Dennoch ist die Ausweitung des Produktionsmaßstabs in den letzten Jahren aufgrund der steigenden Nachfrage nach viralen Vektoren üblich geworden. Angesichts der zahlreichen Herausforderungen, die mit groß angelegten Transfektionsprozessen verbunden sind, besteht der beste Ansatz zur Produktionssteigerung darin, den Prozess zu verkleinern, anstatt ihn zu skalieren. Dieser Top-down-Ansatz ermöglicht eine klare Identifizierung der Bedingungen, die sich auf den Prozess auf industrieller Ebene auswirken, wie z. B. das Volumen der Transfektionskomplexlösung. Dieser Ansatz erleichtert auch die Prozessoptimierung und Entscheidungsfindung. Die Entwicklung solcher Ansätze zur Steigerung der klein angelegten Transfektionsprozesse bietet eine Chance für das Wachstum des europäischen Marktes für Transfektionsreagenzien und -geräte.
Überblick über den europäischen Markt für Transfektionsreagenzien und -geräte
Die Region Europa ist in Großbritannien, Deutschland, Frankreich, Spanien, Italien und den Rest von Europa unterteilt. Das Vereinigte Königreich hält im Jahr 2022 den größten Marktanteil. Das Wachstum der Pharmaindustrie wird durch die im Land laufende qualitativ hochwertige Forschung und Entwicklung sowie die umfangreiche und florierende Wissensbasis im Gesundheitswesen bestimmt. Großbritannien ist eines der weltweit besten Ökosysteme für Forschung, Entwicklung, Herstellung, klinische Anwendung und Erstattung fortschrittlicher Therapeutika. Derzeit laufen im Vereinigten Königreich über 85 klinische Studien, und 70 CGT-Unternehmen streben danach, potenziell kurative Therapien zu entwickeln. Catapult ist ein Top-Unternehmen, das wesentlich zum CGT-Ökosystem im Vereinigten Königreich beigetragen hat. Es gehört zu den fünf führenden Unternehmen, die an der Entwicklung von Herstellungsprozessen für Reagenzien und Geräte im Land beteiligt sind. Das Unternehmen konzentriert sich auf die Entwicklung intelligenterer automatisierter CGT-Herstellungsprozesse, die sich mit minimalem Eingriff automatisch an veränderte Umgebungen und Prozessanforderungen anpassen können. Daher sind die Bemühungen britischer Unternehmen, ihre Produktivität zu steigern und die Endproduktkosten zu senken, die Hauptfaktoren, die das Wachstum des Zell- und Gentherapiemarkts in Großbritannien vorantreiben. Darüber hinaus hat Großbritannien aufgrund nachhaltiger und gezielter Investitionen in die Forschung eine starke Position auf dem Zell- und Gentherapiemarkt in Europa, was dem Markt zusätzlich zugutekommt.
Darüber hinaus sind in Frankreich Biopharma- und Pharmariesen wie Sanofi SA, Ipsen, Pierre Fabre, HRA Pharma und TxCell (Sangamo Therapeutics, Inc.) vertreten. Diese Unternehmen sind unter anderem an der Entwicklung von Impfstoffen und Antikörpern beteiligt, deren Produkte gefriergetrocknet werden müssen, was zur Nachfrage nach Transfektionsreagenzien und -geräten beiträgt.
Umsatz und Prognose des europäischen Marktes für Transfektionsreagenzien und -geräte bis 2030 (Mio. USD)
Segmentierung des europäischen Marktes für Transfektionsreagenzien und -geräte
Der europäische Markt für Transfektionsreagenzien und -geräte ist nach Produkt, Methode, Anwendung, Endbenutzer und Land segmentiert.
Basierend auf dem Produkt ist der europäische Markt für Transfektionsreagenzien und -geräte in Reagenzien und Instrumente unterteilt. Das Segment Reagenzien hatte 2022 einen größeren Anteil.
In Bezug auf die Methode ist der europäische Markt für Transfektionsreagenzien und -geräte in virale Methoden, nicht-virale Methoden und Hybridmethoden segmentiert. Das Segment nicht-virale Methoden hatte 2022 den größten Anteil. Das virale Segment ist in Retroviren, Adenoviren, Adeno-assoziierte Viren und Herpesviren unterteilt. Das nicht-virale Segment ist in physikalische/mechanische Methoden und chemische Methoden unterteilt. Darüber hinaus ist das Segment der physikalischen/mechanischen Methoden in Elektroporation, Mikroinjektion, biolistische Methode, Lasermethode, Magnetofektion und Sonoporation unterteilt. Auch das Segment der chemischen Methoden ist in liposomal/lipidreich und nicht liposomal/lipidreich unterteilt.
Nach Anwendung ist der europäische Markt für Transfektionsreagenzien und -geräte in biomedizinische Forschung, Proteinproduktion und Therapeutikaverabreichung unterteilt. Das Segment biomedizinische Forschung hatte 2022 den größten Anteil.
Basierend auf dem Endverbraucher ist der europäische Markt für Transfektionsreagenzien und -geräte in Hochschulen und Forschungsinstitute sowie Pharma- und Biotechnologieunternehmen unterteilt. Das Segment Hochschulen und Forschungsinstitute hatte 2022 einen größeren Anteil.
Nach Ländern ist der europäische Markt für Transfektionsreagenzien und -geräte in Deutschland, Frankreich, Großbritannien, Italien, Spanien und den Rest von Europa unterteilt. Das Vereinigte Königreich dominierte im Jahr 2022 den europäischen Markt für Transfektionsreagenzien und -geräte.
Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc und Polyplus-Transfection SA sind einige der führenden Unternehmen auf dem europäischen Markt für Transfektionsreagenzien und -geräte.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Transfection Reagents and Equipment Market - Key Market Dynamics
4.1 Europe Transfection Reagents and Equipment Market - Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Popularity of Cell and Gene Therapy
4.2.2 Growing Economic Burden of Cancer
4.3 Market Restraints
4.3.1 High Cost of Instruments and Consumables
4.4 Market Opportunities
4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
4.5 Future Trends
4.5.1 Strategic Initiatives by Companies
4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market - Europe Market Analysis
5.1 Europe Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
5.2 Europe Transfection Reagents and Equipment Market Forecast Analysis
6. Europe Transfection Reagents and Equipment Market Analysis - by Product
6.1 Reagents
6.1.1 Overview
6.1.2 Reagents: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Equipment
6.2.1 Overview
6.2.2 Equipment: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Transfection Reagents and Equipment Market Analysis - by Modality
7.1 Viral
7.1.1 Overview
7.1.2 Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Retrovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.2 Adenovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.3 Adeno-Associated Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.4 Herpes Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Non-Viral
7.2.1 Overview
7.2.2 Non-Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Physical/Mechanical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.1 Electroporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.2 Microinjection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.3 Biolistic Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.4 Laser Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.5 Magnetofection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.6 Sonoporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2 Chemical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.1 Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.2 Non-Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Hybrid
7.3.1 Overview
7.3.2 Hybrid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Transfection Reagents and Equipment Market Analysis - by Application
8.1 Biomedical Research
8.1.1 Overview
8.1.2 Biomedical Research: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Protein Production
8.2.1 Overview
8.2.2 Protein Production: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Therapeutic Delivery
8.3.1 Overview
8.3.2 Therapeutic Delivery: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Transfection Reagents and Equipment Market Analysis - by End Users
9.1 Academic and Research Institutes
9.1.1 Overview
9.1.2 Academic and Research Institutes: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnological Companies: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Transfection Reagents and Equipment Market -Country Analysis
10.1 Europe: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1 Europe: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.2 United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.3 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.4 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.3 Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.3.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.3.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.3.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.3.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.3.2.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.3.2.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.3.3 Germany: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.3.4 Germany: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.4 France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.4.1 France: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.4.2 France: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.4.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.4.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.4.2.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.4.2.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.4.3 France: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.4.4 France: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.5 Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.5.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.5.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.5.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.5.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.5.2.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.5.2.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.5.3 Italy: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.5.4 Italy: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.6 Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.6.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.6.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.6.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.6.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.6.2.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.6.2.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.6.3 Spain: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.6.4 Spain: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.7 Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.7.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.7.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.7.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.7.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.7.2.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.7.2.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.7.3 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.7.4 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by End Users
11. Transfection Reagents and Equipment Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Mirus Bio LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 QIAGEN NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lonza Group AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MaxCyte Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Polyplus-Transfection SA
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
List of Tables
Table 1. Europe Transfection Reagents and Equipment Market Segmentation
Table 2. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
Table 5. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
Table 6. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
Table 7. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
Table 8. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
Table 9. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 10. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
Table 11. Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 12. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 13. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 14. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 15. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 16. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 17. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 18. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 20. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 21. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 22. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 23. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 24. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 25. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 26. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 27. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 28. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 30. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 31. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 32. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 33. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 34. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 35. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 36. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 37. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 38. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 39. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 40. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 41. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 42. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 43. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 44. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 45. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 46. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 47. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 48. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 49. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 50. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 51. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 52. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 53. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 54. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 55. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 56. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 57. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 58. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 59. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 60. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 61. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market
List of Figures
Figure 1. Europe Transfection Reagents and Equipment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Europe Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
Figure 4. Europe Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
Figure 5. Reagents: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Equipment: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Europe Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
Figure 8. Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Retrovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Adenovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adeno-Associated Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Herpes Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Non-Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Physical/Mechanical: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Electroporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Microinjection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Biolistic Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laser Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Magnetofection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Sonoporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Non-Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hybrid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Europe Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
Figure 26. Biomedical Research: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Protein Production: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Therapeutic Delivery: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Europe Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
Figure 30. Academic and Research Institutes: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pharmaceutical and Biotechnological Companies: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Europe: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
Figure 33. Europe: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 34. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 38. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 39. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 40. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
10. Polyplus-Transfection SA
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe transfection reagents and equipment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Europe transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.